M. Gliniak

Relationships between Pulmonary Hypertension Risk, Clinical Profiles, and Outcomes in Dilated Cardiomyopathy

M. Kostkiewicz, P. Podolec, E. Dziewięcka, 2020, Journal of clinical medicine.

Lack of Relationship between Fibrosis-Related Biomarkers and Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis in Dilated Cardiomyopathy

R. Banys, M. Krupiński, P. Podolec, 2021, Cells.

Clinical Utility and Validation of the Krakow DCM Risk Score—A Prognostic Model Dedicated to Dilated Cardiomyopathy

E. Dziewięcka, S. Wiśniowska-Śmiałek, P. Rubis, 2022, Journal of personalized medicine.

Mortality risk in dilated cardiomyopathy: the accuracy of heart failure prognostic models and dilated cardiomyopathy‐tailored prognostic model

P. Podolec, E. Dziewięcka, S. Wiśniowska-Śmiałek, 2020, ESC heart failure.

The burden of atrial fibrillation and its prognostic value in patients with dilated cardiomyopathy.

M. Kostkiewicz, P. Podolec, E. Dziewięcka, 2019, Kardiologia polska.

First experience with sodium-glucose co-transporter 2 inhibitors in Polish patients with cardiovascular diseases.

M. Kostkiewicz, P. Podolec, E. Dziewięcka, 2020, Cardiology journal.

Extended Precordial T Wave Inversions Are Associated with Right Ventricular Enlargement and Poor Prognosis in Pulmonary Hypertension

P. Podolec, M. Waligóra, G. Kopeć, 2021, Journal of clinical medicine.